Bonus Material-16_SD1_Collop

Pdf Summary

This Pulmonary Medicine Board Review presentation by Dr. Nancy Collop from Emory University covers sleep disorders with a focus on obstructive sleep apnea (OSA). Key learning objectives include understanding sleep stages, respiratory physiology changes during sleep, sleep disorder scoring rules, and OSA epidemiology, risk factors, symptoms, comorbidities, and treatments.<br /><br />Sleep consists of four stages: three non-REM stages (N1 light to N3 deep sleep) totaling about 75% of total sleep time, and REM sleep making up about 25%. Aging reduces deep sleep and increases awakenings, while REM remains constant. Respiratory changes during sleep involve decreased tidal volume, minute ventilation, and metabolic rate, with decreased responsiveness to hypoxia and hypercapnia, especially during REM sleep, when breathing is irregular and muscle tone reduced.<br /><br />Polysomnography (PSG) remains the gold standard for diagnosing sleep disorders, while home sleep apnea testing (HSAT) is useful primarily for uncomplicated OSA diagnosis. Scoring respiratory events involves detecting apneas (complete airflow cessation) and hypopneas (partial reductions), with measurements like apnea-hypopnea index (AHI), respiratory disturbance index (RDI), and respiratory events index (REI). Severity is defined by event frequency per hour.<br /><br />OSA affects up to 1 billion globally, with prevalence rising with age and menopause in women. Risk factors include age, male gender (especially <50 years), BMI, ethnicity, genetics, and upper airway anatomy. OSA is linked to hypertension, cardiovascular diseases, stroke, depression, and impaired quality of life but not commonly to severe pulmonary hypertension.<br /><br />Diagnostic approaches prioritize PSG for complex cases (e.g., comorbidities or hypoxemia) and HSAT for straightforward suspected OSA. Questionnaires and history alone are insufficient for diagnosis. Treatment includes lifestyle modifications (weight loss, positional therapy), positive airway pressure (PAP, CPAP favored), oral appliances, surgery (bariatric and maxillomandibular advancement), and novel interventions like hypoglossal nerve stimulation (HGNS). Adherence to PAP therapy is crucial for benefits but challenging.<br /><br />Medications such as solriamfetol and modafinil treat residual sleepiness but do not replace primary OSA therapy. Recent FDA approval of tirzepatide, a GLP-1/GIP receptor agonist, shows promise in reducing OSA severity via weight loss. Overall, management requires individualized approaches and follow-up to optimize therapy adherence and outcomes.

Meta Tag

Concept Obstructive Sleep Apnea

Concept Positive Airway Pressure

Concept Sleep Staging

Concept Non-Rapid Eye Movement Sleep

Concept Rapid eye movement sleep

Concept Apnea

Concept Hypopnea

Keywords

obstructive sleep apnea

polysomnography

home sleep apnea testing

apnea-hypopnea index

sleep stages

respiratory physiology

positive airway pressure

CPAP

hypoglossal nerve stimulation

tirzepatide

Obstructive Sleep Apnea

Positive Airway Pressure

Sleep Staging

Non-Rapid Eye Movement Sleep

Rapid eye movement sleep

Apnea

Hypopnea